2007
DOI: 10.1016/j.poly.2007.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization, X-ray structure and preliminary in vitro antitumor activity of the nitrosyl complex fac-[RuCl3(NO)(dppf)], dppf=1,1′-bis(diphenylphosphine)ferrocene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
33
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(34 citation statements)
references
References 49 publications
1
33
0
Order By: Relevance
“…Among several transition metals, ruthenium has been highlighted in several publications with a diversity of applications in the biological area [2][3][4][5][6][7]. In this sense, ruthenium-based compounds, including phosphines containing ruthenium complexes, constitute active anticancer [4,[8][9][10][11][12][13], antiprotozoals [14,15], and antiviral [16] agents.…”
Section: Introductionmentioning
confidence: 99%
“…Among several transition metals, ruthenium has been highlighted in several publications with a diversity of applications in the biological area [2][3][4][5][6][7]. In this sense, ruthenium-based compounds, including phosphines containing ruthenium complexes, constitute active anticancer [4,[8][9][10][11][12][13], antiprotozoals [14,15], and antiviral [16] agents.…”
Section: Introductionmentioning
confidence: 99%
“…39 Although the slow NO release may narrow some biological applications, such as improving the population spike of neurons, 39 it can act as a prodrug for vasodilation with slow blood pressure decrease, as observed in hypertensive male Wistar rats. 19 On replacing cyclam with four amine ligands the resulting ruthenium tetraamine nitrosyl complexes, 3 ), 4-picoline (4-pic), 4-chloropyridine (4-Clpy), imidazole (imC or imN), 4-acetylpyridine (4-acpy) and L-histidine (L-hist)) and k −NO can be tuned by a judicious choice of the trans ligand L. [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37] In previous theoretical studies we have addressed this issue. 54,55 Unlike Thus, N-(or C-) functionalization could be a suitable approach to control the reactivity of coordinated NO.…”
Section: Introductionmentioning
confidence: 99%
“…27 One of the earliest works of biological activity with biphosphine ligand coordinated to ruthenium complexes was performed with fac-[RuCl 3 (NO)(dppf)] (dppf =1,1′-bis-(diphenylphosphino)ferrocene), which yielded a highly potent compound with IC 50 = 10 ± 3 μmol L −1 in MDA-MB-231 cell line, a value that is lower than those observed for the RuCl 3 NO· 2H 2 O precursor, free dppf ligand and cisplatin. 20 The cytotoxic activity of mer-[RuCl 3 (dppb)H 2 O] (dppb =1,4 bis-(diphenylphospine)butane) against MCF-7, TK-10, and UACC-62 human tumors was of the same order of magnitude as that of the clinical drugs etoposide and colchicines. 21 Therefore, coordination to biphosphine ligands to ruthenium complexes with oxidation state +2 or +3 improved the cytotoxic activity.…”
Section: Introductionmentioning
confidence: 95%